Details of Drug

Drug General Information (ID: D1439)
Drug Name	Salicylic acid (sodium)
Drug Type	Small molecule
Drug Synonymous	Salicylic acid; salicylic acid; 2-Hydroxybenzoic acid; 69-72-7; o-hydroxybenzoic acid; 2-Carboxyphenol; o-Carboxyphenol; Salonil; Rutranex; Retarder W; Keralyt; Freezone; Duoplant; Saligel; Ionil; Psoriacid-S-stift; salicylate; Stri-Dex; Salicylic acid soap; Benzoic acid, 2-hydroxy-; Salicylic acid collodion; Verrugon; Phenol-2-carboxylic acid; Acidum salicylicum; Trans-Ver-Sal; Orthohydroxybenzoic acid; 2-Hydroxybenzenecarboxylic acid; Acido salicilico; Ionil-Plus; Salicylic acid, tech; Kyselina salicylova; Clear away wart remover; Duofil wart; Domerine; Duofilm; Occlusal; SAX; Salicylate; Sebucare; Sebulex; Acido salicilico [Italian]; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; DHS Sal Shampoo; DuoPlant Gel; Duofil wart remover; Hydrisalic Gel; Ionil plus; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; Ortho Hydroxybenzoic Acid; Retarder SAX; Salex Cream; Salex Lotion; CMC_13852; K 537; ATA fraction 10, ammonium salt; Acid, Salicylic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; O-Carboxyphenol; O-hydroxybenzoic acid; Ortho-Hydroxybenzoic Acid; P&S Shampoo; Phenol derivative, 7; Propa pH Peel-Off Acne Mask; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; Salicylic acid & Sulfur Soap; Salicylic acid (TN); Salicylic acid [USAN:JAN]; Acid, 2-Hydroxybenzoic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Dr Scholl's callus removers; Dr Scholl's corn removers; Dr Scholl's wart remover kit; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); Salicylic acid-ring-UL-14C; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); Benzoic acid, 2-hydroxy-(9CI); E9A559BE-383B-4F83-BC02-3031D03D558A; 2 Hydroxybenzoic Acid; 2-hydroxy(1-14c)benzoic acid; SALICYLATE Click to Show/Hide
Disease Class	EA81: Seborrhoeic dermatitis
Therapeutic Class	Antiinflammatory Agents
Structure
Structure	3D Structure		2D Structure
Formula	C7H6O3
InChI	1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)
InChIKey	YGSDEFSMJLZEOE-UHFFFAOYSA-N
Canonical SMILES	C1=CC=C(C(=C1)C(=O)O)O
External Link
	Pubchem ID	338
	CAS Number	69-72-7
	CHEBI ID	16914
	TTD ID	D07HBX
	INTEDE ID	DR1458
	VARIDT ID	DR00556

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM004 Adsorption BM005 Altered gastric pH BM013 Competitive binding of plasma proteins BM014 Interference of cell/tissue uptake BM027 Decreased renal excretion due to nephrotoxicity BM028 Competitive inhibition of renal tubular secretion BM029 Altered urine pH BM032 Decreased renal excretion (Unspecific) BM039 Additive CNS stimulant effects BM050 Increased risk of bleeding BM054 Increased risk of GI mucosal injury/bleeding risk BM055 Increased risk of hepatotoxicity BM058 Increased risk of hyperkalemia BM064 Increased risk of hypoglycemia BM070 Increased risk of metabolic acidosis BM072 Increased risk of nephrotoxicity BM089 Antagonize the effect of antihypertensive agents BM099 Antagonize the effect of uricosuric agents BM107 Attenuated pharmacological effects (Unspecific) BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Salicylic acid (sodium)
Affected gastrointestinal absorption
	Adsorption					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0021		Activated charcoal	C	5462310	Moderate		Inter Info	[67], [68], [69]
	Altered gastric pH					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0603		Esomeprazole	C17H19N3O3S	9568614	Minor		Inter Info	[103], [104], [105]
D0892		Lansoprazole	C16H14F3N3O2S	3883	Minor		Inter Info	[103], [104], [105]
D1179		Omeprazole	C17H19N3O3S	4594	Minor		Inter Info	[103], [104], [105]
D1222		Pantoprazole	C16H15F2N3O4S	4679	Minor		Inter Info	[103], [104], [105]
D0458		Dexlansoprazole	C16H14F3N3O2S	9578005	Minor		Inter Info	[103], [104], [105]
D1373		Rabeprazole	C18H21N3O3S	5029	Minor		Inter Info	[103], [104], [105]
Affected organization distribution
	Competitive binding of plasma proteins					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0012		Acetazolamide	C4H6N4O3S2	1986	Major		Inter Info	[1], [2], [3]
D0521		Dorzolamide (ophthalmic)	C10H16N2O4S3	5284549	Major		Inter Info	[1], [2], [3]
D1018		Methazolamide	C5H8N4O3S2	4100	Major		Inter Info	[1], [2], [3]
D0207		Brinzolamide (ophthalmic)	C12H21N3O5S3	68844	Major		Inter Info	[1], [2], [3]
D0479		Diclofenamide	C6H6Cl2N2O4S2	3038	Major		Inter Info	[1], [2], [3]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[60]
D1677		Valproic acid	C8H16O2	3121	Moderate		Inter Info	[93], [94], [95]
D1283		Phenytoin	C15H12N2O2	1775	Minor		Inter Info	[106], [107], [108]
	Interference of cell/tissue uptake					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1822		Iodide I-123	I-	135300	Moderate		Inter Info	[79], [80], [81]
Affected excretion pathways
	Decreased renal excretion due to nephrotoxicity					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[64], [65], [66]
	Competitive inhibition of renal tubular secretion					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1025		Methotrexate	C20H22N8O5	126941	Major		Inter Info	[5], [6], [7]
	Altered urine pH					Drug Num: 11
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[50], [51], [52]
D0049		Aluminum hydroxide	AlH3O3	10176082	Moderate		Inter Info	[50], [51], [52]
D0236		Calcium carbonate	CCaO3	10112	Moderate		Inter Info	[50], [51], [52]
D0886		Lactic acid	C3H6O3	612	Moderate		Inter Info	[82], [83], [84]
D0968		Magnesium carbonate	CMgO3	11029	Moderate		Inter Info	[50], [51], [52]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[50], [51], [52]
D0974		Magnesium oxide	MgO	14792	Moderate		Inter Info	[50], [51], [52]
D1319		Potassium citrate	C6H5K3O7	13344	Moderate		Inter Info	[82], [83], [84]
D1478		Sodium acetate	C2H3NaO2	517045	Moderate		Inter Info	[82], [83], [84]
D1480		Sodium bicarbonate	CHNaO3	516892	Moderate		Inter Info	[82], [83], [84]
D1654		Tromethamine	C4H11NO3	6503	Moderate		Inter Info	[82], [83], [84]
	Decreased renal excretion (Unspecific)					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[53], [54], [55]
D1323		Pralatrexate	C23H23N7O5	148121	Moderate		Inter Info	[88]
Pharmacodynamic additive effects
	Additive CNS stimulant effects					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[41], [42], [43]
D1092		Moxifloxacin	C21H24FN3O4	152946	Moderate		Inter Info	[41], [42], [43]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Moderate		Inter Info	[41], [42], [43]
D0712		Gatifloxacin	C19H22FN3O4	5379	Moderate		Inter Info	[41], [42], [43]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[42], [43], [41]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[41], [42], [43]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[42], [43], [41]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[41], [42], [43]
D1657		Trovafloxacin	C20H15F3N4O3	62959	Moderate		Inter Info	[41], [42], [43]
	Increased risk of bleeding					Drug Num: 41
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1380		Ramucirumab	NA	NA	Major		Inter Info	[13]
D0005		Abciximab	NA	NA	Moderate		Inter Info	[14], [15], [16]
D0047		Alteplase	NA	NA	Moderate		Inter Info	[20], [21], [22]
D0104		Argatroban	C23H36N6O5S	92722	Moderate		Inter Info	[29], [30], [31]
D0189		Bivalirudin	C98H138N24O33	16129704	Moderate		Inter Info	[29], [30], [31]
D0345		Citalopram	C20H21FN2O	2771	Moderate		Inter Info	[44], [45], [46]
D0364		Clopidogrel	C16H16ClNO2S	60606	Moderate		Inter Info	[15], [47]
D0537		Drotrecogin alfa	NA	NA	Moderate		Inter Info	[29], [30], [31]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[44], [45], [46]
D0588		Eptifibatide	C35H49N11O9S2	448812	Moderate		Inter Info	[14], [15], [16]
D0641		Fenfluramine	C12H16F3N	3337	Moderate		Inter Info	[44], [45], [46]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[44], [45], [46]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[44], [45], [46]
D0690		Fondaparinux	C31H53N3O49S8	5282448	Moderate		Inter Info	[29], [30], [31]
D0904		Lepirudin	C287H440N80O111S6	118856773	Moderate		Inter Info	[29], [30], [31]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[44], [45], [46]
D1395		Reteplase	NA	NA	Moderate		Inter Info	[20], [21], [22]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[29], [30], [31]
D0176		Betrixaban	C23H22ClN5O3	10275777	Moderate		Inter Info	[29], [30], [31]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[44], [45], [46]
D0414		Dalteparin	C26H42N2O37S5	772	Moderate		Inter Info	[29], [30], [31]
D0447		Desirudin	C287H440N80O110S6	16129703	Moderate		Inter Info	[29], [30], [31]
D0451		Desvenlafaxine	C16H25NO2	125017	Moderate		Inter Info	[44], [45], [46]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Moderate		Inter Info	[29], [30], [31]
D0574		Enoxaparin	C26H42N2O37S5	772	Moderate		Inter Info	[29], [30], [31]
D0586		Epoprostenol	C20H32O5	5282411	Moderate		Inter Info	[75], [76], [77]
D0599		Escitalopram	C20H21FN2O	146570	Moderate		Inter Info	[44], [45], [46]
D0753		Heparin	C26H42N2O37S5	772	Moderate		Inter Info	[29], [30], [31]
D0792		Iloprost	C22H32O4	5311181	Moderate		Inter Info	[75], [76], [77]
D1066		Milnacipran	C15H22N2O	65833	Moderate		Inter Info	[44], [45], [46]
D1328		Prasugrel	C20H20FNO3S	6918456	Moderate		Inter Info	[89]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[29], [30], [31]
D1464		Sibutramine	C17H26ClN	5210	Moderate		Inter Info	[44], [45], [46]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[70], [92]
D1696		Vilazodone	C26H27N5O2	6918314	Moderate		Inter Info	[44], [45], [46]
D1550		Tenecteplase	NA	NA	Moderate		Inter Info	[20], [21], [22]
D1593		Tirofiban	C22H36N2O5S	60947	Moderate		Inter Info	[14], [15], [16]
D1625		Treprostinil	C23H34O5	6918140	Moderate		Inter Info	[75], [76], [77]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[44], [45], [46]
D1711		Warfarin	C19H16O4	54678486	Moderate		Inter Info	[29], [30], [31]
D0368		Clove	NA	NA	Minor		Inter Info	[109], [110], [111]
	Increased risk of GI mucosal injury/bleeding risk					Drug Num: 20
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0882		Ketorolac	C15H13NO3	3826	Major		Inter Info	[4]
D0034		Alendronic acid	C4H13NO7P2	2088	Moderate		Inter Info	[17], [18], [19]
D0172		Betamethasone	C22H29FO5	9782	Moderate		Inter Info	[35], [36], [37]
D0671		Fludrocortisone	C21H29FO5	31378	Moderate		Inter Info	[35], [36], [37]
D0773		Hydrocortisone	C21H30O5	5754	Moderate		Inter Info	[35], [36], [37]
D0783		Ibandronate	C9H23NO7P2	60852	Moderate		Inter Info	[17], [18], [19]
D1217		Pamidronic acid	C3H11NO7P2	4674	Moderate		Inter Info	[17], [18], [19]
D1332		Prednisolone	C21H28O5	5755	Moderate		Inter Info	[35], [36], [37]
D1334		Prednisone	C21H26O5	5865	Moderate		Inter Info	[35], [36], [37]
D1412		Risedronic acid	C7H11NO7P2	5245	Moderate		Inter Info	[17], [18], [19]
D0215		Budesonide	C25H34O6	5281004	Moderate		Inter Info	[35], [36], [37]
D0436		Deflazacort	C25H31NO6	189821	Moderate		Inter Info	[35], [36], [37]
D0453		Dexamethasone	C22H29FO5	5743	Moderate		Inter Info	[35], [36], [37]
D0623		Etidronic acid	C2H8O7P2	3305	Moderate		Inter Info	[17], [18], [19]
D1041		Methylprednisolone	C22H30O5	6741	Moderate		Inter Info	[35], [36], [37]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[70]
D1628		Triamcinolone	C21H27FO6	31307	Moderate		Inter Info	[35], [36], [37]
D1630		Triamcinolone (ophthalmic)	C21H27FO6	31307	Moderate		Inter Info	[35], [36], [37]
D1727		Zoledronic acid	C5H10N2O7P2	68740	Moderate		Inter Info	[17], [18], [19]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[102]
	Increased risk of hepatotoxicity					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[10], [11], [12]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[10], [11], [12]
	Increased risk of hyperkalemia					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0585		Eplerenone	C24H30O6	443872	Moderate		Inter Info	[56], [57], [58]
D0536		Drospirenone	C24H30O3	68873	Moderate		Inter Info	[73], [74]
	Increased risk of hypoglycemia					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Moderate		Inter Info	[38], [39], [40]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[38], [39], [40]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[61], [62], [63]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[61], [62], [63]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Moderate		Inter Info	[61], [62], [63]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Moderate		Inter Info	[61], [62], [63]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[61], [62], [63]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[61], [62], [63]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[61], [62], [63]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[38], [39], [40]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[38], [39], [40]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[38], [39], [40]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[38], [39], [40]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Moderate		Inter Info	[61], [62], [63]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Moderate		Inter Info	[61], [62], [63]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[61], [62], [63]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[61], [62], [63]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[38], [39], [40]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[38], [39], [40]
	Increased risk of nephrotoxicity					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0432		Deferasirox	C21H15N3O4	214348	Major		Inter Info	[8], [9]
D0056		Amikacin	C22H43N5O13	37768	Moderate		Inter Info	[23], [24], [25]
D0057		Amikacin (liposome)	C22H43N5O13	37768	Moderate		Inter Info	[23], [24], [25]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[48], [27], [49]
D0718		Gentamicin	C21H43N5O7	3467	Moderate		Inter Info	[23], [24], [25]
D0876		Kanamycin	C18H36N4O11	6032	Moderate		Inter Info	[23], [24], [25]
D1304		Plazomicin	C25H48N6O10	42613186	Moderate		Inter Info	[23], [24], [25]
D1507		Streptomycin	C21H39N7O12	19649	Moderate		Inter Info	[23], [24], [25]
D1597		Tobramycin	C18H37N5O9	36294	Moderate		Inter Info	[23], [24], [25]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[85], [86], [87]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[85], [86], [87]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[85], [86], [87]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antihypertensive agents					Drug Num: 42
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[26], [27], [28]
D0156		Benazepril	C24H28N2O5	5362124	Moderate		Inter Info	[32], [33], [34]
D0567		Enalapril	C20H28N2O5	5388962	Moderate		Inter Info	[32], [33], [34]
D0587		Eprosartan	C23H24N2O4S	5281037	Moderate		Inter Info	[59], [4], [56]
D0695		Fosinopril	C30H46NO7P	55891	Moderate		Inter Info	[32], [33], [34]
D0865		Isradipine	C19H21N3O5	3784	Moderate		Inter Info	[26], [27], [28]
D0938		Lisinopril	C21H31N3O5	5362119	Moderate		Inter Info	[32], [33], [34]
D0954		Losartan	C22H23ClN6O	3961	Moderate		Inter Info	[59], [4], [56]
D1082		Moexipril	C27H34N2O7	91270	Moderate		Inter Info	[32], [33], [34]
D1130		Nicardipine	C26H29N3O6	4474	Moderate		Inter Info	[26], [27], [28]
D1138		Nimodipine	C21H26N2O7	4497	Moderate		Inter Info	[26], [27], [28]
D1141		Nisoldipine	C20H24N2O6	4499	Moderate		Inter Info	[26], [27], [28]
D1170		Olmesartan	C24H26N6O3	158781	Moderate		Inter Info	[59], [4], [56]
D1256		Perindopril	C19H32N2O5	107807	Moderate		Inter Info	[32], [33], [34]
D1369		Quinapril	C25H30N2O5	54892	Moderate		Inter Info	[32], [33], [34]
D1379		Ramipril	C23H32N2O5	5362129	Moderate		Inter Info	[32], [33], [34]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[70], [71], [72]
D0138		Azilsartan medoxomil	C30H24N4O8	135409642	Moderate		Inter Info	[59], [4], [56]
D0254		Captopril	C9H15NO3S	44093	Moderate		Inter Info	[32], [33], [34]
D0640		Felodipine	C18H19Cl2NO4	3333	Moderate		Inter Info	[26], [27], [28]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[78]
D0844		Irbesartan	C25H28N6O	3749	Moderate		Inter Info	[59], [4], [56]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[26], [27], [28]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[26], [27], [28]
D1545		Telmisartan	C33H30N4O2	65999	Moderate		Inter Info	[59], [4], [56]
D1618		Trandolapril	C24H34N2O5	5484727	Moderate		Inter Info	[32], [33], [34]
D1679		Valsartan	C24H29N5O3	60846	Moderate		Inter Info	[59], [4], [56]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[26], [27], [28]
D0117		Atenolol	C14H22N2O3	2249	Minor		Inter Info	[96], [97], [98]
D0173		Betaxolol	C18H29NO3	2369	Minor		Inter Info	[96], [97], [98]
D0188		Bisoprolol	C18H31NO4	2405	Minor		Inter Info	[96], [97], [98]
D0602		Esmolol	C16H25NO4	59768	Minor		Inter Info	[96], [97], [98]
D0884		Labetalol	C19H24N2O3	3869	Minor		Inter Info	[96], [97], [98]
D1049		Metoprolol	C15H25NO3	4171	Minor		Inter Info	[96], [97], [98]
D1357		Propranolol	C16H21NO2	4946	Minor		Inter Info	[96], [97], [98]
D0010		Acebutolol	C18H28N2O4	1978	Minor		Inter Info	[96], [97], [98]
D0267		Carvedilol	C24H26N2O4	2585	Minor		Inter Info	[96], [97], [98]
D1098		Nadolol	C17H27NO4	39147	Minor		Inter Info	[96], [97], [98]
D1114		Nebivolol	C22H25F2NO4	71301	Minor		Inter Info	[96], [97], [98]
D1293		Pindolol	C14H20N2O2	4828	Minor		Inter Info	[96], [97], [98]
D1498		Sotalol	C12H20N2O3S	5253	Minor		Inter Info	[96], [97], [98]
D1585		Timolol	C13H24N4O3S	33624	Minor		Inter Info	[96], [97], [98]
	Antagonize the effect of uricosuric agents					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1341		Probenecid	C13H19NO4S	4911	Moderate		Inter Info	[70], [90], [91]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0217		Bumetanide	C17H20N2O5S	2471	Minor		Inter Info	[99], [100], [101]
D0613		Etacrynic acid	C13H12Cl2O4	3278	Minor		Inter Info	[99], [100], [101]
D0704		Furosemide	C12H11ClN2O5S	3440	Minor		Inter Info	[99], [100], [101]
D1812		Hyaluronidase	C17H24BrNO2	91820602	Minor		Inter Info	[112], [113], [114]
D1611		Torasemide	C16H20N4O3S	41781	Minor		Inter Info	[99], [100], [101]

References
1	Cowan RA, Hartnell GG, Lowdell CP, Baird IM, Leak AM "Metabolic acidosis induced by carbonic anhydrase inhibitors and salicylates in patients with normal renal function." Br Med J (Clin Res Ed) 289 (1984): 347-8. [PMID: 6432091]
2	Sweeney KR, Chapron DJ, Brandt JL, Gomolin IH, Feig PU, Kramer PA "Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation." Clin Pharmacol Ther 40 (1986): 518-24. [PMID: 3769383]
3	Sweeney KR, Chapron DJ, Kramer PA "Effect of salicylate on serum protein binding and red blood cell uptake of acetazolamide in vitro." J Pharm Sci 77 (1988): 751-6. [PMID: 3225768]
4	Product Information. Toradol (ketorolac). Roche Laboratories, Nutley, NJ.
5	Kraus A, Alarcon-Segovia D "Low dose MTX and NSAID induced "mild" renal insufficiency and severe neutropenia." J Rheumatol 18 (1991): 1274. [PMID: 1796967]
6	Steele WH, Lawrence JR, Stuart JF, McNeill CA. "The protein binding of methotrexate in the serum of patients with neoplastic disease."?Cancer Chemother Pharmacol. 1981;7(1):61-64.[PMID: 7340989]
7	Taylor JR, Halprin KM "Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding." Arch Dermatol 113 (1977): 588-91.[PMID: 856048]
8	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
9	Rafat C, Fakhouri F, Ribeil JA, Delarue R, Le Quintrec M "Fanconi Syndrome Due to Deferasirox." Am J Kidney Dis (2009):. [PMID: 19493602]
10	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
11	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
12	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
13	Product Information. Cyramza (ramucirumab). Eli Lilly and Company, Indianapolis, IN.
14	Hirsch J, Dalen J, Guyatt G, American College of Chest Physicians "The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Physicians." Chest 119(1 Suppl) (2001): 1S-2S. [PMID: 11157638]
15	Klinkhardt U, Kirchmaier CM, Westrup D, Graff J, Mahnel R, Breddin HK, Harder S "Ex vivo-in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A." Clin Pharmacol Ther 67 (2000): 305-13. [PMID: 10741635]
16	Product Information. Integrilin (eptifibatide). Schering Laboratories, Kenilworth, NJ.
17	Product Information. Actonel (risedronate). Procter and Gamble Pharmaceuticals, Cincinnati, OH.
18	Product Information. Bonefos (clodronate). Rhone-Poulenc Rorer Canada Inc, Laval, QC.
19	Product Information. Didronel I.V. Infusion (etidronate). MGI Pharma Inc, Minnetonka, MN.
20	Harder S, Klinkhardt U "Thrombolytics: drug interactions of clinical significance." Drug Saf 23 (2000): 391-9. [PMID: 11085346]
21	Product Information. Abbokinase (urokinase). Abbott Pharmaceutical, Abbott Park, IL.
22	Product Information. TNKase (tenecteplase) Genentech, South San Francisco, CA.
23	Farag MM, Mikhail MR, Abdel-Meguid E, Abdel-Tawab S "Assessment of gentamicin-induced nephrotoxicity in rats treated with low doses of ibuprofen and diclofenac sodium." Clin Sci 91 (1996): 187-91. [PMID: 8795442]
24	Gagliardi L "Possible indomethacin-aminoglycoside interaction in preterm infants." J Pediatr 107 (1985): 991-2. [PMID: 4067765]
25	Scott CS, RetschBogart GZ, Henry MM "Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen." Pediat Pulm 31 (2001): 314-6. [PMID: 11288217]
26	Deleeuw PW "Nonsteroidal anti-inflammatory drugs and hypertension: the risks in perspective." Drugs 51 (1996): 179-87. [PMID: 8808162]
27	Product Information. Arthrotec (diclofenac-misoprostol). Searle, Skokie, IL.
28	Ring ME, Corrigan JJ, Fenster PE "Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin." Thromb Res 44 (1986): 391-400. [PMID: 3798404]
29	Fausa O "Salicylate-induced hypoprothrombinemia: a report of four cases." Acta Med Scand 188 (1970): 403-8. [PMID: 5490567]
30	Koch-Weser J, Sellers EM "Drug interactions with coumarin anticoagulants (first of two parts)." N Engl J Med 285 (1971): 487-98. [PMID: 4397794]
31	Wells PS, Holbrook AM, Crowther NR, Hirsh J "Interactions of warfarin with drugs and food." Ann Intern Med 121 (1994): 676-83. [PMID: 7944078]
32	Ahmad S "Indomethacin-enalapril interaction: an alert." South Med J 84 (1991): 411-2. [PMID: 2000541]
33	Silberbauer K, Stanek B, Templ H "Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition." Br J Clin Pharmacol 14 (1982): s87-93. [PMID: 6753910]
34	Townend JN, Doran J, Lote CJ, Davies MK "Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril." Br Heart J 73 (1995): 434-41. [PMID: 7786658]
35	Hansen RA, Tu W, Wang J, Ambuehl R, McDonald CJ, Murray MD "Risk of adverse gastrointestinal events from inhaled corticosteroids." Pharmacotherapy 28 (2008): 1325-34. [PMID: 18956992]
36	Koren G, Roifman C, Gelfand E, Lavi S, Suria D, Stein L "Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis." Ther Drug Monit 9 (1987): 177-9. [PMID: 3617157]
37	Piper JM, Ray WA, Daugherty JR, Griffin MR "Corticosteroid use and peptic ulcer disease: role of nonsteroidal ani-inflammatory drugs." Ann Intern Med 114 (1991): 735-40. [PMID: 2012355]
38	Christensen LK, Hansen JM, Kristensen M "Sulphaphenazole-induced hypoglycemic attacks in tolbutamide-treated diabetics." Lancet 2 (1963): 1298-301. [PMID: 14071924]
39	Field JB, Ohta M, Boyle C, Remer A "Potentiation of acetohexamide hypoglycemia by phenylbutazone." N Engl J Med 277 (1967): 889-94. [PMID: 6061822]
40	Turtle JR, Burgess JA "Hypoglycemic action of fenfluramine in diabetes mellitus." Diabetes 22 (1973): 858-67. [PMID: 4749404]
41	Davey PG "Overview of drug interactions with the quinolones." J Antimicrob Chemother 22(suppl c) (1988): 97-107. [PMID: 3053579]
42	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
43	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
44	Bannister SJ, Houser VP, Hulse JD, Kisicki JC, Rasmussen JG "Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin." Acta Psychiatr Scand Suppl 350 (1989): 102-6. [PMID: 2530759]
45	Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30. [PMID: 9796863]
46	Skop BP, Brown TM "Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors." Psychosomatics 37 (1996): 12-6. [PMID: 8600488]
47	Product Information. Plavix (clopidogrel). Bristol-Myers Squibb, Princeton, NJ.
48	Deray G, Le Hoang P, Aupetit B, Achour A, Rottembourg J, Baumelou A "Enhancement of cyclosporine A nephrotoxicity by diclofenac." Clin Nephrol 27 (1987): 213-4. [PMID: 2953512]
49	Sesin GP, O'Keefe E, Roberto P "Sulindac-induced elevation of serum cyclosporine concentration." Clin Pharm 8 (1989): 445-6. [PMID: 2663332]
50	Covington TR, Lawson LC, Young LL, eds. "Handbook of Nonprescription Drugs. 10th ed." Washington, DC: American Pharmaceutical Association (1993):.
51	Gaspari F, Vigano G, Locatelli M, Remuzzi G "Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis." Am J Kidney Dis 11 (1988): 338-42
52	Levy G, Lampman T, Kamath BL, Garrettson LK "Decreased serum salicylate concentrations in children with rheumatic fever treated with antacid." N Engl J Med 293 (1975): 323-5
53	Rodin SM, Johnson BF "Pharmacokinetic interactions with digoxin." Clin Pharmacokinet 15 (1988): 227-44. [PMID: 3056649]
54	Finch MB, Johnston GD, Kelly JG, McDevitt DG "Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy." Br J Clin Pharmacol 17 (1984): 353-5
55	Jorgensen HS, Christensen HR, Kampmann JP "Interaction between digoxin and indomethacin or ibuprofen." Br J Clin Pharmacol 31 (1991): 108-10
56	Radack KL, Deck CC, Bloomfield SS "Ibuprofen interferes with the efficacy of antihypertensive drugs: a randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen." Ann Intern Med 107 (1987): 628-35. [PMID: 2889416]
57	Abdel-Haq B, Magagna A, Favilla S, Salvetti A "Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects." J Cardiovasc Pharmacol 18 (1991): s33-6. [PMID: 1725198]
58	Moore TJ, Crantz FR, Hollenberg NK "Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension." Hypertension 3 (1981): 168-73. [PMID: 6260645]
59	Multum Information Services, Inc. Expert Review Panel.
60	Juarez-Olguin H, Jung-Cook H, Flores-Perez J, Asseff IL "Clinical Evidence of an Interaction Between Imipramine and Acetylsalicylic Acid on Protein Binding in Depressed Patients." Clin Neuropharmacol 25 (2002): 32-36. [PMID: 11852294]
61	Asplund K, Wiholm BE, Lithner F "Glibenclamide-associated hypoglycaemia: a report on 57 cases." Diabetologia 24 (1983): 412-7. [PMID: 6411511]
62	Product Information. Apidra (insulin glulisine). Aventis Pharmaceuticals, Bridgewater, NJ.
63	Semel JD, Wortham E, Karl DM "Fasting hypoglycemia associated with disopyramide." Am Heart J 106 (1983): 1160-1. [PMID: 6356848]
64	Tietjen DP "Recurrence and specificity of nephrotic syndrome due to tolmetin." Am J Med 87 (1989): 354-5
65	Shand DG, Epstein C, Kinberg-Calhoun J, et al "The effect of etodolac administration on renal function in patients with arthritis." J Clin Pharmacol 26 (1986): 269-74
66	Turner GA, Walker RJ, Bailey RR, et al "Sulindac-induced acute interstitial nephritis." N Z Med J 97 (1984): 239-40
67	Ilkhanipour K, Yealy DM, Krenzelok EP "Activated charcoal surface area and its role in multiple-dose charcoal therapy." Am J Emerg Med 11 (1993): 583-5. [PMID: 8240556]
68	Naveau S, Bonhomme L, Preaux N, Chaput JC "A pure charcoal suspension for colonoscopic tattoo." Gastrointest Endosc 37 (1991): 624-5. [PMID: 1756921]
69	Reed MD "Oral activated charcoal therapy." Am J Emerg Med 6 (1988): 318. [PMID: 3370115]
70	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
71	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
72	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA."
73	Ponce SP, Jennings AE, Madias NE, Harrington JT "Drug-induced hyperkalemia." Medicine (Baltimore) 64 (1985): 357-70. [PMID: 2865667]
74	Product Information. Yasmin (drospirenone-ethinyl estradiol) Berlex Laboratories, Richmond, CA.
75	Product Information. Flolan (epoprostenol). Glaxo Wellcome, Research Triangle Park, NC.
76	Product Information. Remodulin (treprostinil). United Therapeutics Corp, Silver Spring, MD.
77	Product Information. Ventavis (iloprost). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
78	Cinquegrani MP, Liang CS "Indomethacin attenuates the hypotensive action of hydralazine." Clin Pharmacol Ther 39 (1986): 564-70
79	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
80	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
81	Product Information. Sodium Iodide I-123 (sodium iodide I-123). GE Healthcare, Princeton, NJ.
82	Berg KJ "Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency." Eur J Clin Pharmacol 11 (1977): 111-6. [PMID: 837963]
83	Brouwers JRBJ, Desmet PAGM "Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs." Clin Pharmacokinet 27 (1994): 462-85. [PMID: 7882636]
84	Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT "Diuresis or urinary alkalinisation for salicylate poisoning?" Br Med J (Clin Res Ed) 285 (1982): 1383-6. [PMID: 6291695]
85	Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
86	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
87	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
88	Product Information. Folotyn (pralatrexate). Allos Therapeutics, Westminster, CO.
89	Product Information. Effient (prasugrel). Lilly, Eli and Company, Indianapolis, IN.
90	Harris M, Bryant LR, Danaher P, Alloway J "Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis." J Rheumatol 27 (2000): 2873-6. [PMID: 11128679]
91	Regal RE "Aspirin and uricosurics: interaction revisited." Drug Intell Clin Pharm 21 (1987): 219-20. [PMID: 3829916]
92	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
93	Dasgupta A, Jacques M "Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera - role of uremic compounds." Am J Clin Pathol 101 (1994): 349-53. [PMID: 8135194]
94	Farrell K, Orr JM, Abbott FS, et al "The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in children." J Pediatr 101 (1982): 142-4. [PMID: 6806458]
95	Orr JM, Abbott FS, Farrell K, Ferguson S, Sheppard I, Godolphin W "Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects." Clin Pharmacol Ther 31 (1982): 642-9. [PMID: 6804150]
96	Zanchetti A, Hansson L, Leonetti G, et al. "Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy." J Hypertens 20 (2002): 1015-1022. [PMID: 12011664]
97	Sziegoleit W, Rausch J, Polak G, et al "Influence of acetylsalicylic acid on acute circulatory effects of the beta-blocking agents pindolol and propranolol in humans." Int J Clin Pharmacol Ther Toxicol 20 (1982): 423-30
98	Keber I, Jerse M, Keber D, Stegnar M "The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease." Br J Clin Pharmacol 7 (1979): 287-91
99	Bartoli E, Arras S, Faedda R, Soggia G, Satta A, Olmeo NA "Blunting of furosemide diuresis by aspirin in man." J Clin Pharmacol 20 (1980): 452-8
100	Valette H, Apoil E "Interaction between salicylate and two loop diuretics." Br J Clin Pharmacol 8 (1979): 592-4
101	Cheng Z, Radominska-Pandya A, Tephly TR. Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. Drug Metab Dispos. 1999 Oct;27(10):1165-70.
102	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
103	Miner PB Jr, Fort JG, Zhang Y. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325?mg + immediate-release omeprazole 40?mg) or enteric-coated aspirin 325?mg + enteric-coated omeprazole 40?mg - a randomised, phase 1, crossover study.?Aliment Pharmacol Ther. 2013;38(1):62-71. [PMID: 23692061]
104	Inarrea P, Esteva F, Cornudella R, Lanas A "Omeprazole does not interfere with the antiplatelet effect of low-dose aspirin in man." Scand J Gastroenterol 35 (2000): 242-6. [PMID: 10766315]
105	Nefesoglu FZ, Ayanoglu-Dulger G, Ulusoy NB, Imeryuz N "Interaction of omeprazole with enteric-coated salicylate tablets." Int J Clin Pharmacol Ther 36 (1998): 549-53. [PMID: 9799060]
106	Fraser DG, Ludden TM, Evens RP, Sutherland EW "Displacement of phenytoin from plasma binding sites by salicylate." Clin Pharmacol Ther 27 (1980): 165-9. [PMID: 7353334]
107	Leonard RF, Knott PJ, Rankin GO, et al "Phenytoin-salicylate interaction." Clin Pharmacol Ther 29 (1981): 56-60. [PMID: 7460475]
108	Neuvonen PJ, Lehtovaara R, Bardy A, Elomaa E "Antipyretic analgesics in patients on antiepileptic drug therapy." Eur J Clin Pharmacol 15 (1979): 263-8. [PMID: 314381]
109	Heck AM, DeWitt BA, Lukes AL "Potential interactions between alternative therapies and warfarin." Am J Health Syst Pharm 57 (2000): 1221-7 quiz 1228-30. [PMID: 10902065]
110	Saeed SA, Gilani AH "Antithrombotic activity of clove oil." J Pak Med Assoc 44 (1994): 112-5. [PMID: 8078176]
111	Srivasta KC "Antiplatelet principles from a food spice clove (Syzygium aromaticum L) [corrected]" Prostaglandins Leukot Essent Fatty Acids 48 (1993): 363-72. [PMID: 8321872]
112	Fuhr U, Maier-Bruggemann A, Blume H, et al. "Grapefruit juice increases oral nimodipine bioavailability." Int J Clin Pharmacol Ther 36 (1998): 126-32. [PMID: 9562227]
113	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
114	Product Information. Vitrase (hyaluronidase). Bausch and Lomb, Rochester, NY.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence